Related Experiment Video
Updated: Mar 4, 2026

Assessment of Morphine-induced Hyperalgesia and Analgesic Tolerance in Mice Using Thermal and Mechanical Nociceptive Modalities
Published on: July 29, 2014
miR-219-5p targets CaMKIIγ to attenuate morphine tolerance in rats
Jian Wang1, Wei Xu1, Jiali Shao1
1Department of Anesthesiology, Xiangya Hospital, Central South University, Changsha, Hunan 410008, China.
Abstract:
Morphine tolerance is a clinical challenge in pain management. Emerging evidence suggests that microRNA (miRNA) plays a regulatory role in the development of morphine tolerance. miR-219-5p (miR-219) targets calmodulin-dependent protein kinase II γ (CaMKIIγ) to activate central pain sensitization via N-methyl-D-aspartate (NMDA) receptor. Therefore, we hypothesized that miR-219-5p attenuates morphine tolerance by targeting CaMKIIγ. We found that the expression of miR-219-5p was decreased significantly after chronic morphine treatment. Overexpression of miR-219-5p by lentivirus injection prevents the development of morphine tolerance. CaMKIIγ, the target gene of miR-219-5p was downregulated by overexpression of miR-219-5p both in vivo and in vitro. Furthermore, we found that lentiviral-mediated miR-219-5p decreased the expression of NMDA receptor subunit 1 (NR1), leading to attenuation of morphine tolerance. Overall, the data demonstrate that miR-219-5p plays a crucial role in alleviating morphine tolerance by inhibiting the CaMKII/NMDA receptor pathway. Overexpression of miR-219-5p may be a potential strategy to ameliorate morphine tolerance.
Insights
MicroRNA-219-5p (miR-219) alleviates morphine tolerance by inhibiting the CaMKII/NMDA receptor pathway. Restoring miR-219 levels may offer a novel strategy for managing pain and reducing tolerance to morphine.
Area of Science:
- Neuroscience
- Molecular Biology
- Pharmacology
Background:
- Morphine tolerance presents a significant challenge in clinical pain management.
- MicroRNAs (miRNAs) are increasingly recognized for their regulatory roles in morphine tolerance development.
- miR-219-5p is implicated in central pain sensitization by targeting CaMKIIγ and activating NMDA receptors.
Purpose of the Study:
- To investigate the role of miR-219-5p in attenuating morphine tolerance.
- To elucidate the molecular mechanism involving CaMKIIγ and NMDA receptors.
Main Methods:
- Chronic morphine treatment in vivo and in vitro models.
- Lentiviral vectors for miR-219-5p overexpression.
- Quantitative analysis of miR-219-5p, CaMKIIγ, and NMDA receptor subunit 1 (NR1) expression.
Main Results:
- Chronic morphine treatment significantly decreased miR-219-5p expression.
- Overexpression of miR-219-5p prevented morphine tolerance development.
- miR-219-5p overexpression downregulated CaMKIIγ and NR1 expression, inhibiting the CaMKII/NMDA pathway.
Conclusions:
- miR-219-5p plays a critical role in alleviating morphine tolerance.
- Inhibition of the CaMKII/NMDA receptor pathway by miR-219-5p is the underlying mechanism.
- Overexpression of miR-219-5p represents a potential therapeutic strategy for morphine tolerance.
Related Concept Videos
Opioid Receptors: Overview
Analgesia and Pain Management

